Extrait

• To establish effectiveness of ofatumumab in combination with bendamustine in patients with indolent B-cell NHL disease relapsed after rituximab therapy.

Critère d'inclusion

• Indolent B-cell Non-Hodgkin’s Lymphoma

Liens

• euctr
• euctr
• ictrp
• ictrp
• euctr
• ictrp
• ictrp
• ictrp
• ictrp
• euctr
• ictrp
• euctr
• euctr
• ictrp
• euctr
• euctr
• euctr
• ictrp